Cargando…

Composite risk stratification models optimise the value of imaging in prostate cancer staging

Detalles Bibliográficos
Autores principales:	McAllister, Tom, Gnanapragasam, Vincent, Thurtle, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447204/ https://www.ncbi.nlm.nih.gov/pubmed/37636205 http://dx.doi.org/10.1002/bco2.253

Ejemplares similares

Novel concepts for risk stratification in prostate cancer
por: Patel, Keval M, et al.
Publicado: (2016)

Understanding of prognosis in non-metastatic prostate cancer: a randomised comparative study of clinician estimates measured against the PREDICT prostate prognostic model
por: Thurtle, David R., et al.
Publicado: (2019)

Comparative performance and external validation of the multivariable PREDICT Prostate tool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)
por: Thurtle, David, et al.
Publicado: (2020)

Incorporating multiparametric MRI staging and the new histological Grade Group system improves risk-stratified detection of bone metastasis in prostate cancer
por: Thurtle, David, et al.
Publicado: (2016)

Improving the safety and tolerability of local anaesthetic outpatient transperineal prostate biopsies: A pilot study of the CAMbridge PROstate Biopsy (CAMPROBE) method
por: Thurtle, D, et al.
Publicado: (2018)

Models predicting survival to guide treatment decision-making in newly diagnosed primary non-metastatic prostate cancer: a systematic review
por: Thurtle, David, et al.
Publicado: (2019)

Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model
por: Thurtle, David R., et al.
Publicado: (2019)

Optimising preoperative risk stratification tools for prostate cancer using mpMRI
por: Reisæter, Lars A. R., et al.
Publicado: (2017)

Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study
por: Gnanapragasam, Vincent J., et al.
Publicado: (2016)

Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation
por: Parry, M. G., et al.
Publicado: (2020)

Comments on the value of ECG changes in risk stratification of COVID‐19 patients
por: Murat, Selda, et al.
Publicado: (2021)

Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification
por: Davik, Petter, et al.
Publicado: (2022)

Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification
por: Gennaro, Kyle H., et al.
Publicado: (2018)

The next age of immunotherapy: optimisation, stratification and therapeutic synergies
por: Halama, Niels
Publicado: (2018)

Novel three-dimensional bone ‘mapping’ software can help assess progression of osseous metastases from routine CT
por: Thurtle, D., et al.
Publicado: (2017)

Imaging-Based Obesity Assessment for Risk Factor Stratification and Prognostication in Malignancy
por: Cowen, Jake E., et al.
Publicado: (2022)

Prostate Abscess in an Adolescent With AIDS
por: McAllister, Shane C., et al.
Publicado: (2015)

Update on the Risks of Electronic Cigarettes—Vaping
por: Reasoner, Jeremiah J., et al.
Publicado: (2020)

Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”
por: McAnally, Heath B., et al.
Publicado: (2021)

Reply: Imaging-Based Obesity Assessment for Risk Factor Stratification and Prognostication in Malignancy
por: Liu, Elizabeth E., et al.
Publicado: (2022)

Added Value of Postoperative Radioiodine Scan for Staging and Risk Stratification in Papillary Thyroid Microcarcinoma
por: Kaewchur, Tawika, et al.
Publicado: (2021)

Cardiovascular disease risk stratification in type 2 diabetes
por: Esdaile, Harriet, et al.
Publicado: (2022)

Risk Stratification and Anticoagulation in Low-risk Non-valvular Atrial Fibrillation
por: Arya, Arash
Publicado: (2013)

Optimising TNM Staging of Patients with Prostate Cancer Using WB-MRI
por: Pasoglou, Vassiliki, et al.
Publicado: (2016)

Risk stratification of primary liver cancer
por: Tan, You-Wen
Publicado: (2022)

Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply
por: Markusse, Iris M., et al.
Publicado: (2015)

Morphomolecular staging to improve stratification of patients with node-negative pancreatic cancer
por: Shi, Xiaohan, et al.
Publicado: (2023)

Biomarkers for prostate cancer detection and risk stratification
por: Farha, Mark W., et al.
Publicado: (2022)

Multi Modality Imaging Features of Cardiac Myxoma
por: McAllister, Brylie J.
Publicado: (2020)

Optimising (18)F-Choline PET/CT Acquisition Protocol in Prostate Cancer Patients
por: Massaro, Arianna, et al.
Publicado: (2012)

Radionuclide molecular imaging of abdominal aortic aneurysms for risk stratification and non‐invasive therapy assessment
por: Gandhi, Richa, et al.
Publicado: (2021)

Management of noncompaction requires optimisation
por: Finsterer, Josef, et al.
Publicado: (2019)

Risk stratification in hospitalized COVID-19 patients
por: Horvath, Angela, et al.
Publicado: (2021)

Prostate Region-Wise Imaging Biomarker Profiles for Risk Stratification and Biochemical Recurrence Prediction
por: Sánchez Iglesias, Ángel, et al.
Publicado: (2023)

(68)Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients
por: Zang, Shiming, et al.
Publicado: (2017)

Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification
por: Guldvik, Ingrid J., et al.
Publicado: (2020)

On Risk Estimation versus Risk Stratification in Early Prostate Cancer
por: Carlsson, Sigrid V., et al.
Publicado: (2016)

General practitioner perception of prostate-specific antigen testing has improved, but more awareness of prostate cancer risk in younger patients is still awaited
por: Thurtle, David R., et al.
Publicado: (2018)

Entering an era of radiogenomics in prostate cancer risk stratification
por: Soodana-Prakash, Nachiketh, et al.
Publicado: (2018)

Radiogenomics influence on the future of prostate cancer risk stratification
por: Banerjee, Vinayak, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q117obpt7lur6lbndsjcvstb95